[ET Net News Agency, 26 May 2025] REMEGEN (09995) fell 10.3% to HK$45.95.
It hits an intra-day low of HK$45.9, and an intra-day high of HK$51.7. The total shares traded was 12.47 million, with a value of HK$602.28m. The active buy/sell ratio is 40:60, with net selling turnover of HK$111.88m. CHINA INNOVATION MARKET SER accounts for greatest net responsive buying turnover of HK$33.64m, with volume weighted average price of HK$48.164. CHINA INV INFO accounts for greatest net responsive selling turnover of HK$32.05m, with volume weighted average price of HK$48.159.
Basic Information| Nominal | 45.950 | % Chg | -10.25% |
| High | 51.700 | Low | 45.900 |
| Shares Tr | 12.47m | Turnover | 602.28m |
| 10-D SMA | 44.295 | %H.V | 104.225 |
| 20-D SMA | 41.835 | VWAP | 48.290 |
| 50-D SMA | 31.703 | RSI14 | 61.784 |
Status: Active buy/sell ratio is 40:60, with net selling turnover of HK$111.88m
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| REMEGEN (09995) | 45.95 | -10.25 |
| 3SBIO (01530) | 18.64 | -7.03 |
| EVEREST MED (01952) | 42.25 | -1.05 |
| LAEKNA-B (02105) | 17.44 | -1.80 |
| WUXI XDC (02268) | 35.95 | -2.57 |
| ASCENTAGE-B (06855) | 48.10 | -4.85 |
| SKB BIO-B (06990) | 318.00 | -0.13 |
| ZAI LAB (09688) | 23.55 | -6.18 |
| AKESO (09926) | 81.45 | -2.04 |
| INNOCARE (09969) | 10.24 | -3.40 |
(ed)
Nominal 